Article

Pharmacists on Capitol Hill Top SPT Week in Review

Author(s):

Top news of the week from Specialty Pharmacy Times.

5. The Price of Non-Optimized Medication Therapy

Pharmacists can help optimize medication regimens to produce the best patient outcomes at the lowest cost. Read more.

4. Novel Immunotherapy Combo for Lung Cancer Shows Promise in Early Trial

The therapy is a combination of a checkpoint drug, nivolumab, and a new immune stimulation drug, ALT-803. Read more.

3. Hospital Payment Reform: Experimental Program Highlights Need for Improvement

An experimental program in Maryland aimed to reduce health care spending by shifting away from hospital-based care and toward less costly, primary, preventive, and outpatient services. Read more.

2. New Drug Targets Specific Gene Fusions in Rare Pediatric Cancers

Pediatric patients treated with larotrectinib in a clinical trial demonstrated a 93% response rate. Read more.

1. PBM Transparency, DIR Fees Top Priorities for Pharmacists on Capitol Hill

Community pharmacists urge Congress to support 3 priority bills that create transparency for pharmacy benefit managers and improve patient access. Read more.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards